| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2019 | A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing miR-34a and deregulating the DRD4/Akt/mTOR signaling axis | Wen, YT; Wu, ATH; Bamodu, OA; Wei, L; Lin, CM; Yen, Y; Chao, TY; Mukhopadhyay, D; Hsiao, M ; Huang, HS | Cancers 11(10), 1442 | | | |
| 2021 | A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling | Wu, ATH; Huang, HS; Wen, YT; Lawal, B; Mokgautsi, N; Huynh, TT; Hsiao, M ; Wei, L | CELLS 10(9), 2391 | | | |
| 2022 | Neuronal splicing regulator RBFOX3 mediates seizures via regulating Vamp1 expression preferentially in NPY-expressing GABAergic neurons | Huang, DF; Lee, CY; Chou, MY; Yang, TY; Cao, X; Hsiao, YH; Wu, RN; Lien, CC; Huang, YS ; Huang, HP; Gau, SS; Huang, HS | Proceedings of the National Academy of Sciences of the United States of America 119(33), e2203632119 | | | |
| 2014 | Pharmacologic Down-regulation of EZH2 Suppresses Bladder Cancer in vitro and in vivo | Tang, SH; Huang, HS; Wu, HU; Tsai, YT; Chuang, MJ; Yu, CP; Huang, SM; Sun, GH; Chang, SY; Hsiao, PW; Yu, DS; Cha, TL | Oncotarget 5(21), 10342-10355 | | | |
